Home › NCT07281118
Intercostal Cryoanalgesia in Double Lung Transplant Recipients
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adults ≥18 years of age * Undergoing double lung transplantation via bilateral thoracotomies or clamshell incision Exclusion Criteria: * Multi-organ transplant recipients * Redo lung transplant recipients
About the study
This study is testing a new way to help manage pain after a double lung transplant. Instead of relying only on strong pain medicines like opioids, doctors will use a cold-therapy probe during surgery to help numb the nerves near the incision. Researchers want to see if this method can reduce the need for opioids and improve recovery.
What is being tested
- Atricure CryoSPHERE MAX Probe (device)
Sponsor: University of California, Los Angeles · Participants: 148 · Started: Dec 16, 2025
Contact the study team
- Steven Stokes · Phone: 310-206-7436
- Jenny Lester, MPH · Phone: 310-794-9728
Official record on ClinicalTrials.gov — NCT07281118
Locations in the U.S.
| California | University of California Los Angeles, Los Angeles University of California San Francisco, San Francisco (Not yet recruiting) |
| Texas | Baylor University, Waco (Not yet recruiting) |
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.